Medicared For All Logo

Gregory Carlsen MD in Danville, Kentucky

Home Kentucky Danville

Gregory Carlsen MD has Radiation Oncology as his primary medical specialty. Their primary office is: 520 Techwood Dr N in Danville, Kentucky. There is an additional office location, for a total of two, for Gregory Carlsen MD that can be viewed further down. They attended University Of Kentucky College Of Medicine and graduated in 1995 (around 29 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Gregory H Carlsen MD Office Phone and Directions

Gregory Carlsen MD
520 Techwood Dr N
Danville, Kentucky 40422
859-236-9819


Patient Ratings
Please rate your experience with Gregory Carlsen MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 859-236-9819


Enter a starting address:


Healthcare Info for Gregory Carlsen MD

Medical School: University Of Kentucky College Of Medicine
Graduation Year: 1995
The Primary Medical Specialty for Gregory Carlsen MD is listed as: Radiation Oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 29
PAC (PECOS ID)#: 5092610576
NPI #: 1306831516
NPI Created On: 09/14/2005
NPI Last Updated Listed as: 11/23/2016
Primary Taxonomy Code: 2085R0001X
License Number:
32606
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • CareSource
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Ct scan guidance for insertion of radiation therapy fields
  2. Management of radiation therapy, complex
  3. Management of radiation therapy simulation, simple
  4. Management of radiation therapy, simulation, complex
  5. Respiratory motion management simulation
  6. Management of radiation therapy, 3d
  7. Calculation of radiation therapy dose
  8. Management of modulation radiotherapy planning
  9. Special radiation therapy planning
  10. Radiation treatment devices, design and construction, complex
  11. Radiation therapy consultation per week
  12. Design and construction of device for radiation therapy
  13. Radiation therapy consultation
  14. Radiation treatment management, 5 treatments
  15. Special radiation treatment procedure
  16. New patient office or other outpatient visit, typically 20 minutes
  17. New patient office or other outpatient visit, typically 30 minutes
  18. Established patient office or other outpatient visit, typically 10 minutes
  19. Established patient office or other outpatient visit, typically 15 minutes
  20. Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788096835

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788096837

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788096839

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788096841

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788096843

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 799849589

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: ONCOLOGY

Name of Drug #1: FOUNDATIONONE

Drug or Biological: Device

Product Category #2: ONCOLOGY

Name Of Drug #2:: FOUNDATIONONE HEME

Drug or Biological #3:: Device

Product Category #3: ONCOLOGY

Name of Drug: FOUNDATIONONE CDX

Drug or Biological: Device

Product Category #4: ONCOLOGY

Name of Drug #4: FOUNDATIONFOCUS

Drug or Biological #4:: Device

Product Category #5: ONCOLOGY

Name of Drug #5: FOUNDATIONONE LIQUID CDX


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 819155063

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802882121

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: ZEJULA

Open Associated Drug #1: 69656-103-90


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812627377

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: PIQRAY

Open Associated Drug #1: 0078-0708-02


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812627375

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: LUTATHERA

Open Associated Drug #1: 69488-003-01


Additional Office Locations

1.
2 Physicians Park
Frankfort, KY 40601
Group Members: 0

Phone: 859-236-9819

Enter a starting address:


Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry